Lung cancer is one of the most frequently diagnosed cancers and is the leading cause of cancer-related death worldwide. Non-small-cell lung cancer (NSCLC), a heterogeneous class of tumours, represents approximately 85% of all new lung cancer diagnoses. T
Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29[CrossRef], [PubMed], [Web of Science 庐]View all references. Non-small cell lung cancer (NSCLC), which accounts for 87% of lung cancer, is most commonly diagnosed at an advanced stage, when it is essentially incurable, with ...
Cancer statistics, 2023. CA Cancer J. Clin. 73, 17–48 (2023). Article PubMed Google Scholar Wang, Y. et al. Survival trends among patients with metastatic non-small cell lung cancer before and after the approval of immunotherapy in the United States: a Surveillance, Epidemiology, and ...
Cancer statistics, 2013. CA Cancer J. Clin. 63, 11–30 (2013). Article PubMed Google Scholar Ettinger, D. S. et al. Non-Small Cell Lung Cancer, Version 2.2013. J. Natl Compr. Canc. Netw. 11, 645–653 (2013). Article PubMed Google Scholar Davidson, M. R., Gazdar, A. F...
Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer. New England Journal of Medicine. 2015;373:123–35. 15. Borghaei H, Paz-Ares L, Horn L, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373:1627–...
Lung cancer is still the leading cause of cancer-related mortality. Over the past two decades, the management of non-small cell lung cancer (NSCLC) has undergone a significant revolution. Since the first identification of activating mutations in the epid
Non-small cell lung cancer (NSCLC) Minimal residual disease (MRD) Circulating tumor DNA (ctDNA) Prognostic assessment Recurrence monitoring Introduction Lung cancer is the second most common cancer worldwide. According to global cancer statistics, there will be 2.2 million new lung cancer patients an...
Current studies indicate that fluorine-18-fluorodeoxyglucose positron emission tomography/ computed tomography ([18F]FDG PET/CT) is the most accurate imaging modality for the detection of relapsed locally advanced non-small cell lung cancer (NSCLC) after curatively intended chemoradiotherapy. To this day...
Worldwide, lung cancer is the most common cause of cancer-related deaths. Molecular targeted therapies and immunotherapies for non-small-cell lung cancer (NSCLC) have improved outcomes markedly over the past two decades. However, the vast majority of adv
www.nature.com/scientificdata OPEN An integrated single-cell Analysis transcriptomic dataset for non-small cell lung cancer Karolina Hanna Prazanowska 1,2 & Su Bin Lim 1,2 ✉ As single-cell RNA sequencing (scRNA-seq) has emerged as a great tool for studying ...